Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
PT Swayasa Prakarsa is an Indonesian biotechnology and medical device company that serves as a commercialization vehicle for research products developed at Universitas Gadjah Mada (UGM). The company specializes in the manufacturing and distribution of locally developed healthcare solutions, most notably Gama-CHA, a bovine-derived bone graft substitute used in dental and orthopedic surgeries. In addition to medical devices, Swayasa Prakarsa produces a range of standardized herbal medicines targeting chronic conditions such as hypertension and diabetes. The company operates a dedicated manufacturing facility in Yogyakarta and plays a critical role in reducing Indonesia's dependence on imported medical supplies through academic-industry collaboration. Their portfolio also includes diagnostic kits and personal care products derived from natural ingredients.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on PT Swayasa Prakarsa.